GeoVax nabs $1.9M from NIH for HIV/AIDS vax research; Mexico launches a program to vaccinate 5th-grade girls against HPV;

 @AlisonBFierce: Merck's HPV vaccine Gardasil was proved safe in a Kaiser study, the second of its kind in the past year. More | Follow @AlisonBFierce

> Dalton and University of Guelph will collaborate to develop an anti-TB vaccine. Release

> The World Bank and United Nations will provide Pakistan with $43.5 million to procure polio vaccine under the National Emergency Action Plan. Item

> BioDiem launched a $2.5 million rights issue to raise funds for its various vaccine and infectious disease development programs. Article

> Mexico on Wednesday launched a massive program to vaccinate fifth-grade girls against human papillomavirus, making it one of the few nations in the world with a universal campaign against the sexually transmitted virus. Story

> Medicago and Cellectis made progress toward production of biosimilar products in tobacco plants. News

And Finally... GeoVax landed a $1.9 million grant from the National Institute of Allergy and Infectious Diseases, a division of National Institutes of Health, for its HIV/AIDS vaccine program. More

Read more here:

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.